LYNX1-mediated mechanisms could be potentially linked to the increased risk of epilepsy based on a patient-specific gene expression profile enriched with known genes associated with epilepsy in NPCs derived from one FXS donor with epilepsy. The gene discussed is LYNX1; the disease is epilepsy.